Literature DB >> 1958439

The effects of two anti-vertigo drugs (betahistine and prochlorperazine) on driving skills.

T Betts1, D Harris, E Gadd.   

Abstract

1. The effects of betahistine 72 mg three times daily, prochlorperazine 5 mg three times daily and placebo taken for 3 days before testing were compared on two actual driving tasks (weaving and gap estimation) and two psychomotor tasks (reaction time and kinetic visual acuity) in normal subjects in a double-blind prospectively randomised cross-over study. 2. The psychomotor effects of betahistine could not be distinguished from those of placebo. 3. Prochlorperazine impaired driving performance causing increased carelessness and slowing on the weaving test. 4. There was little subjective appreciation of impairment whilst taking prochlorperazine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1958439      PMCID: PMC1368605          DOI: 10.1111/j.1365-2125.1991.tb03930.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Comparative sedative effects of a barbiturate and some tranquilizer drugs on normal subjects.

Authors:  T A LOOMIS; T C WEST
Journal:  J Pharmacol Exp Ther       Date:  1958-04       Impact factor: 4.030

Review 2.  Ménière's disorder.

Authors:  T J Wilmot
Journal:  Clin Otolaryngol Allied Sci       Date:  1979-04

3.  Effect of diphenidol and prochlorperazine on semicircular canal function in man.

Authors:  A J Benson
Journal:  Aerosp Med       Date:  1969-06

4.  [Betaserc (Betahistine-HC1) in the treatment of acute deafness].

Authors:  B Grahne; M Paavolainen
Journal:  Med Monatsschr       Date:  1976-06

5.  Betahistine in peripheral vertigo: a double-blind, placebo-controlled, cross-over study of Serc versus placebo.

Authors:  P Canty; J Valentine
Journal:  J Laryngol Otol       Date:  1981-07       Impact factor: 1.469

6.  Performance studies with the H1-histamine receptor antagonists, astemizole and terfenadine.

Authors:  A N Nicholson; B M Stone
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

7.  Betahistine hydrochloride in Méniére's disease.

Authors:  I J Frew; G N Menon
Journal:  Postgrad Med J       Date:  1976-08       Impact factor: 2.401

8.  Effects of two antihistamine drugs on actual driving performance.

Authors:  T Betts; D Markman; S Debenham; D Mortiboy; T McKevitt
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-28

9.  Neuroleptic affinities for human brain receptors and their use in predicting adverse effects.

Authors:  E Richelson
Journal:  J Clin Psychiatry       Date:  1984-08       Impact factor: 4.384

10.  Drug-induced parkinsonism in the elderly.

Authors:  P J Stephen; J Williamson
Journal:  Lancet       Date:  1984-11-10       Impact factor: 79.321

View more
  10 in total

1.  Betahistine: a retrospective synopsis of safety data.

Authors:  Sabine Jeck-Thole; Wolfgang Wagner
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 2.  Menière's disease: pathophysiology and treatment.

Authors:  H Thai-Van; M J Bounaix; B Fraysse
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Effect of the novel histamine H4 receptor antagonist SENS-111 on spontaneous nystagmus in a rat model of acute unilateral vestibular loss.

Authors:  Mathieu Petremann; Cindy Gueguen; Viviana Delgado Betancourt; Eric Wersinger; Jonas Dyhrfjeld-Johnsen
Journal:  Br J Pharmacol       Date:  2019-08-28       Impact factor: 8.739

4.  Betahistine dihydrochloride with and without early vestibular rehabilitation for the management of patients with balance disorders following head trauma: a preliminary randomized clinical trial.

Authors:  Maged B Naguib; Yasser T Madian
Journal:  J Chiropr Med       Date:  2014-03

Review 5.  Histamine and betahistine in the treatment of vertigo: elucidation of mechanisms of action.

Authors:  M Lacour; O Sterkers
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 6.  Management of peripheral vertigo with antihistamines: New options on the horizon.

Authors:  Jonas Dyhrfjeld-Johnsen; Pierre Attali
Journal:  Br J Clin Pharmacol       Date:  2019-07-22       Impact factor: 4.335

Review 7.  Medications and impaired driving.

Authors:  Amanda Hetland; David B Carr
Journal:  Ann Pharmacother       Date:  2014-01-28       Impact factor: 3.154

8.  Potential enhancing effects of histamine H₁ agonism/H₃ antagonism on working memory assessed by performance and bold response in healthy volunteers.

Authors:  P van Ruitenbeek; M A Mehta
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

9.  Effectiveness of a Vestibular Rehabilitation Protocol to Improve the Health-Related Quality of Life and Postural Balance in Patients with Vertigo.

Authors:  Heloísa Freiria Tsukamoto; Viviane de Souza Pinho Costa; Rubens Alexandre da Silva; Gislaine Garcia Pelosi; Luciana Lozza de Moraes Marchiori; Cláudia Regina Sanches Vaz; Karen Barros Parron Fernandes
Journal:  Int Arch Otorhinolaryngol       Date:  2015-05-06

10.  Betahistine in the treatment of Ménière's disease.

Authors:  Michel Lacour; Paul H van de Heyning; Miroslav Novotny; Brahim Tighilet
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.